Associated Papers
Alpha-Synuclein Neurobiology in Parkinson's Disease: A Comprehensive Review of Its Role, Mechanisms, and Therapeutic Perspectives.
Pitton Rissardo J et al.
Brain Sciences, 2025
α-Synuclein-dependent increases in PIP5K1γ drive inositol signaling to promote neurotoxicity.
Horvath JD et al.
Cell Reports, 2023
miRNA and antisense oligonucleotide-based α-synuclein targeting as disease-modifying therapeutics in Parkinson's disease.
Suvarna V et al.
Frontiers in Pharmacology, 2022
Different Effects of α-Synuclein Mutants on Lipid Binding and Aggregation Detected by Single Molecule Fluorescence Spectroscopy and ThT Fluorescence-Based Measurements.
Ruf VC et al.
Acs Chemical Neuroscience, 2019
Mitochondrial dysfunction and neurodegenerative proteinopathies: mechanisms and prospects for therapeutic intervention.
Briston T et al.
Biochemical Society Transactions, 2018
Alpha-synuclein targets the plasma membrane via the secretory pathway and induces toxicity in yeast.
Dixon C et al.
Genetics, 2005
Select a paper to view details